57 related articles for article (PubMed ID: 32864832)
1. Risk of Recurrence in Differentiated Thyroid Cancer: A Population-Based Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems.
Gan T; Huang B; Chen Q; Sinner HF; Lee CY; Sloan DA; Randle RW
Ann Surg Oncol; 2019 Sep; 26(9):2703-2710. PubMed ID: 30830539
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Utility of Tumor Stage versus American Thyroid Association Risk Class in Thyroid Cancer.
Abiri A; Pang J; Prasad KR; Goshtasbi K; Kuan EC; Armstrong WB; Haidar YM; Tjoa T
Laryngoscope; 2023 Jan; 133(1):205-211. PubMed ID: 35716358
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Pathological Prognostic Stage and Anatomic Stage Groups According to the Updated Version of the American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8th Edition.
Ibis K; Ozkurt S; Kucucuk S; Yavuz E; Saip P
Med Sci Monit; 2018 May; 24():3637-3643. PubMed ID: 29849016
[TBL] [Abstract][Full Text] [Related]
4. Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma.
McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; Wasif N
J Gastrointest Surg; 2012 Jan; 16(1):53-61; discussion 61. PubMed ID: 21972055
[TBL] [Abstract][Full Text] [Related]
5. The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.
Kim K; Kim JH; Park IS; Rho YS; Kwon GH; Lee DJ
World J Surg; 2018 Nov; 42(11):3624-3631. PubMed ID: 29750323
[TBL] [Abstract][Full Text] [Related]
6. Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
Janczewski LM; Browner A; Cotler J; Nelson H; Ballman KV; LeBlanc M; Gollub MJ; Eng C; Brierley JD; Palefsky JM; Goldberg RM; Goodman KA; Washington MK; Asare EA; Palis B
Cancer; 2024 May; 130(9):1702-1710. PubMed ID: 38140735
[TBL] [Abstract][Full Text] [Related]
7. Has the 8th American joint committee on cancer TNM staging improved prognostic performance in oral cancer? A systematic review.
Erazo-Puentes MC; Sánchez-Torres A; Aguirre-Urizar JM; Bara-Casaus J; Gay-Escoda C
Med Oral Patol Oral Cir Bucal; 2024 Mar; 29(2):e163-e171. PubMed ID: 38368527
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer.
Janczewski LM; Faski J; Nelson H; Gollub MJ; Eng C; Brierley JD; Palefsky JM; Goldberg RM; Washington MK; Asare EA; Goodman KA;
CA Cancer J Clin; 2023; 73(5):516-523. PubMed ID: 37114458
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer.
Janczewski LM; Browner AE; Cotler JH; Nelson H; Kakar S; Carr NJ; Hanna NN; Holowatyj AN; Goldberg RM; Washington MK; Asare EA; Overman MJ;
CA Cancer J Clin; 2023; 73(6):590-596. PubMed ID: 37358310
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy and the disease recurrence of patients previously treated for differentiated thyroid cancer: A systematic review and meta analysis.
Shan R; Li X; Tao M; Xiao W; Chen J; Mei F; Song S; Sun B; Yuan C; Liu Z
Chin Med J (Engl); 2024 Mar; 137(5):547-555. PubMed ID: 38311812
[TBL] [Abstract][Full Text] [Related]
11. American joint committee on cancer staging of uveal melanoma.
Mellen PL; Morton SJ; Shields CL
Oman J Ophthalmol; 2013 May; 6(2):116-8. PubMed ID: 24082672
[TBL] [Abstract][Full Text] [Related]
12. Geographic disparities in thyroid cancer staging at presentation: Insights from an Australian context.
Yang ZM; Tong CW; Bhimani N; O'Neill CJ; Lai CSL; Serpell JW; Glover AR
World J Surg; 2024 May; ():. PubMed ID: 38733313
[TBL] [Abstract][Full Text] [Related]
13. Correction to: Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis.
Russo E; Guizzardi M; Canali L; Gaino F; Costantino A; Mazziotti G; Lania A; Uccella S; Di Tommaso L; Ferreli F; Malvezzi L; Spriano G; Mercante G
Rev Endocr Metab Disord; 2024 Apr; 25(2):449-450. PubMed ID: 37979073
[No Abstract] [Full Text] [Related]
14. Correlation analysis between BRAF
Wen J; Liu H; Lin Y; Liang Z; Wei L; Zeng Q; Wei S; Zhang L; Yang W
Heliyon; 2024 May; 10(9):e29955. PubMed ID: 38726195
[TBL] [Abstract][Full Text] [Related]
15. The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study.
Yang Z; Heng Y; Zhao Q; Hao D; Tao L; Deng X; Cai W; Qiu W
Cancer Med; 2023 Jun; 12(12):13270-13278. PubMed ID: 37140212
[TBL] [Abstract][Full Text] [Related]
16. Nomogram Predicts Overall Survival in Patients With Stage IV Thyroid Cancer (TC): A Population-Based Analysis From the SEER Database.
Yang T; Hu T; Zhao M; He Q
Front Oncol; 2022; 12():919740. PubMed ID: 35898883
[TBL] [Abstract][Full Text] [Related]
17. Impacts of the American Joint Committee on Cancer (AJCC) 8
Thewjitcharoen Y; Chatchomchuan W; Karndumri K; Porramatikul S; Krittiyawong S; Wanothayaroj E; Butadej S; Nakasatien S; Veerasomboonsin V; Kanchanapituk A; Rajatanavin R; Himathongkam T
Heliyon; 2021 Mar; 7(3):e06624. PubMed ID: 33869853
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Nodule Evaluation and Management in Older Adults: A Review of Practical Considerations for Clinical Endocrinologists.
Ospina NS; Papaleontiou M
Endocr Pract; 2021 Mar; 27(3):261-268. PubMed ID: 33588062
[TBL] [Abstract][Full Text] [Related]
19. Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-Analysis.
Lechner MG; Bernardo AC; Lampe A; Praw SS; Tam SH; Angell TE
Oncologist; 2021 Feb; 26(2):e251-e260. PubMed ID: 32864832
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
